Monic(Roengvoraphoj)DrescherMD

Hematologic Oncology

Instructor, Medicine, Geisel School of Medicine

Dr. Drescher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Medical Center Dr
Dhmc- Department Of Hematology/Oncology
Lebanon, NH 03756
Phone+1 603-650-6763

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2006 - 2009
Medizinische Fakultät Universität zu KölnClass of 2005

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 2...
Robert D McBane 2nd, Charles L Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen Sanfilippo
Journal of Thrombosis and Haemostasis. 2024-12-20
6 citations
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.
Robert D McBane 2nd, Charles L Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen Sanfilippo
Journal of Thrombosis and Haemostasis. 2024-06-01
52 citations
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
Deborah Schrag, Hajime Uno, Rachel Rosovsky, Cynthia Rutherford, Kristen Sanfilippo
JAMA. 2023-06-13

Abstracts/Posters

Perioperative Bridging of Anticoagulation _ Does Protocol Adherence Improve Outcomes?
Monic R. Drescher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019